Abstract

The potential regulation of protein trafficking by calmodulin (CaM) is a novel concept that remains to be substantiated. We proposed that KCNQ2 K+ channel trafficking is regulated by CaM binding to the C-terminal A and B helices. Here we show that the L339R mutation in helix A, which is linked to human benign neonatal convulsions, perturbs CaM binding to KCNQ2 channels and prevents their correct trafficking to the plasma membrane. We used glutathione S-transferase fused to helices A and B to examine the impact of this and other mutations in helix A (I340A, I340E, A343D, and R353G) on the interaction with CaM. The process appears to require at least two steps; the first involves the transient association of CaM with KCNQ2, and in the second, the complex adopts an "active" conformation that is more stable and is that which confers the capacity to exit the endoplasmic reticulum. Significantly, the mutations that we have analyzed mainly affect the stability of the active configuration of the complex, whereas Ca2+ alone appears to affect the initial binding step. The spectrum of responses from this collection of mutants revealed a strong correlation between adopting the active conformation and channel trafficking in mammalian cells. These data are entirely consistent with the concept that CaM bound to KCNQ2 acts as a Ca2+ sensor, conferring Ca2+ dependence to the trafficking of the channel to the plasma membrane and fully explaining the requirement of CaM binding for KCNQ2 function.

Highlights

  • We proposed that KCNQ2 K؉ channel trafficking is regulated by CaM binding to the C-terminal A and B helices

  • M-type channels are generated by the KCNQ (Kv7) family of voltage-gated subtypes (1), and they are found throughout the nervous system where they fulfill dominant roles in the control of excitability and neural discharges (2)

  • No difference in fluorescence was observed when the interaction between D-CaM and the reference A343D and I340E mutants was assayed, the two mutants linked to benign familial neonatal convulsions (BFNC) and the I340A mutant produced a moderate effect on the maximal fluorescence emission (Fig. 2 and Table 1)

Read more

Summary

EXPERIMENTAL PROCEDURES

Molecular Biology—The human KCNQ2 (Y15065) and KCNQ3 (NM004519) cDNAs were kindly provided by T. J. Jentsch (Leibniz-Institut fur Molekulare Pharmakologie, Berlin, Germany), and all of the deletions, point mutations, and epitope insertions in KCNQ subunits were constructed by PCR-based mutagenesis. The cDNAs encoding the rat CaM and the Ca2ϩ-independent form of CaM (CaM1234), in which the first aspartate of each EF hand is replaced by alanine, were provided by the group of J. P. Adelman (Vollum Institute, Oregon Health Sciences University, Portland, OR). The KCNQ2 subunit was tagged at the N terminus with a tandem repeat of five Myc epitopes (MEQKLISEEDLN), whereas the KCNQ3 subunit was tagged

The abbreviations used are
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call